Clinical Trial Update: Plasma Aldosterone Levels and Atrial Fibrillation Reduction (ALDO-AF Study)

View source ↗

Summary

The ALDO-AF Study investigates whether plasma aldosterone levels influence reduction of atrial fibrillation. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: University Hospital, Caen | Conditions: Atrial Fibrillation, Aldosterone | Status: UNKNOWN